BMAA is thought to promote neurodegeneration ultimately resulting in ALS/PDC through a non-excitatory mechanism involving altered cell physiology taking place within the nervous systems of organisms exposed to low doses of the toxin over long periods of time. This evidence concerns the gene PDC and amyotrophic lateral sclerosis.